Menu

Vibrio Infections On the Rise

Increases in oceanic populations of these bacteria—both pathogenic and not—is an effect of climate change, scientists show.

Aug 9, 2016
Alison F. Takemura

Vibrio choleraeWIKIMEDIA; TOM KIRN, RON TAYLOR, LOUISA HOWARDVibrio cholerae, V. vulnificus, and V. parahemolyticus can cause life-threatening infections. The risk they pose is also growing. As ocean temperatures have climbed over the last five decades, both Vibrio population sizes and infection rates have risen in regions the North Atlantic and the North Sea, according to a study published yesterday (August 8) in PNAS.

Scientists continue to observe an increase in outbreaks of marine infections—which can cause disease in humans, coral, and other organisms—as a result of changing ocean conditions. Researchers from the University of Genoa, Italy, and their international colleagues analyzed formalin-preserved plankton samples to determine changes in Vibrio abundances along the North Atlantic from 1958 to 2011.  

Study coauthor Rita Colwell of the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, expressed concern, particularly for places that haven’t historically experienced high rates of Vibrio infections, such as the rapidly warming Baltic Sea in Northern Europe. “They are now reporting more Vibrio in their waters,” she told New Scientist. “Not because it wasn’t there before, but because the water was too cold [for them to bloom]. Vibrio responds very quickly to temperature.”

The same pattern is also happening in the U.S. “We have seen Vibrio outbreaks in places that were previously too cold for Vibrio, like parts of Alaska,” Karen Wong from the US Centers for Disease Control and Prevention’s  division of foodborne, waterborne and environmental diseases, who was not involved in the study, told New Scientist.

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics
Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics
Ready-to-use immunoassay kit increases analytical output and productivity in bioprocess workflows. Kit developed as part of licensing and supply agreement with Cygnus Technologies
IDT launches ultra-high performance CRISPR Cas12a enzyme
IDT launches ultra-high performance CRISPR Cas12a enzyme
IDT’s new CRISPR Cas12a (Cpf1) Ultra enzyme can target new sites within the genome and with greater efficiency
Implen Launches New NanoPhotometer N120: The High Throughput Champion!
Implen Launches New NanoPhotometer N120: The High Throughput Champion!
Implen GmbH is excited to announce the release of the NanoPhotometer® N120, an absorbance based UV/VIS Multi Channel Spectrophotometer.
StemExpress Announces Release of New Frozen Leukopak® to Advance Research
StemExpress Announces Release of New Frozen Leukopak® to Advance Research
To continue to provide new products and services to further advance medical research around the world, today, StemExpress announced the release of their Frozen Leukopak®.